Linde PLC Board and Executive Compensation Changes

Ticker: LIN · Form: 8-K · Filed: 2024-11-04T00:00:00.000Z

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

TL;DR

Linde PLC board shakeup: New directors elected, one departs. Exec comp details also filed.

AI Summary

Linde PLC announced on October 29, 2024, changes in its board of directors and executive compensation. Specifically, the company reported the departure of Director David Schanzer and the election of new directors, including Dr. Robert L. Massie and Dr. David L. Schanzer, to the board. The filing also details compensatory arrangements for certain officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial risks indicated.

Key Players & Entities

FAQ

Who has departed from Linde PLC's board of directors?

David Schanzer has departed from Linde PLC's board of directors as of October 29, 2024.

Who has been elected to Linde PLC's board of directors?

Dr. Robert L. Massie and Dr. David L. Schanzer have been elected to Linde PLC's board of directors.

What is the reporting date for this 8-K filing?

The date of the earliest event reported is October 29, 2024.

What are the main topics covered in this 8-K filing?

This filing covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is Linde PLC's jurisdiction of incorporation?

Linde PLC is incorporated in Ireland.

From the Filing

0001654954-24-013677.txt : 20241104 0001654954-24-013677.hdr.sgml : 20241104 20241104140209 ACCESSION NUMBER: 0001654954-24-013677 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241029 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241104 DATE AS OF CHANGE: 20241104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LINDE PLC CENTRAL INDEX KEY: 0001707925 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38730 FILM NUMBER: 241422530 BUSINESS ADDRESS: STREET 1: FORGE, 43 CHURCH STREET WEST CITY: WOKING SURREY STATE: X0 ZIP: GU216HT BUSINESS PHONE: 00441483242200 MAIL ADDRESS: STREET 1: FORGE, 43 CHURCH STREET WEST CITY: WOKING SURREY STATE: X0 ZIP: GU216HT FORMER COMPANY: FORMER CONFORMED NAME: ZAMALIGHT PLC DATE OF NAME CHANGE: 20170622 FORMER COMPANY: FORMER CONFORMED NAME: PRAXAIR DATE OF NAME CHANGE: 20170614 FORMER COMPANY: FORMER CONFORMED NAME: ZAMALIGHT PLC DATE OF NAME CHANGE: 20170530 8-K 1 linde_8k.htm FORM 8-K linde_8k.htm 0001707925 false 0001707925 2024-10-29 2024-10-29 0001707925 dei:OtherAddressMember 2024-10-29 2024-10-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   DATE OF REPORT (Date of earliest event reported): October 29, 2024   LINDE PLC (Exact name of registrant as specified in its charter)   Ireland   001-38730   98-1448883 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   10 Riverview Dr. Danbury , Connecticut United States 06810   Forge 43 Church Street West Woking , Surrey GU21 6HT United Kingdom   (Address of principal executive offices) (Zip Code)   +44 1483 242200 (Registrant’s telephone numbers, including area code)   (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:     Title of each class   Trading symbol(s)   Name of each exchange on which registered Ordinary shares (€0.001 nominal value per share)   LIN   Nasdaq Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐           Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoin

View on Read The Filing